Thursday, 27 January 2022

Covaxin, Covishield get regular market nod, with some riders

Drug regulator DCGI on Thursday granted regular marketing authorisation to the two commonly used Covid vaccines — Covishield and Covaxin — for use in adults with certain conditions. However, the vaccines will be available only under “programmatic setting” and all vaccinations have to be recorded on CoWIN. Via Times of India https://ift.tt/2hJjhqE

No comments:

Post a Comment